AI4HF was proudly represented at the IEEE Metroxraine 2025 Conference by Carina Dantas of SHINE 2Europe, who delivered a presentation on the project’s study: Policy Perspectives on Challenges, Barriers and Potential Enablers of Large-Scale AI-Driven Solutions in Cardiology—soon to be published as a peer-reviewed article by IEEE.
The presentation highlighted the critical role of governance, ethics, and regulatory readiness in ensuring that AI technologies can be safely and effectively integrated into chronic heart failure care.
AI4HF is advancing the development of AI solutions for personalized risk assessment while also addressing the policy and societal frameworks essential for trustworthy deployment. The study explores the intersection of technology, regulation, and clinical practice, identifying the key enablers and barriers to successful AI adoption in healthcare systems.
Based on multi-stakeholder research—including co-design workshops, regulatory analysis, and stakeholder consultations—the study emphasizes that the impact of AI extends beyond predictive performance. Successful implementation depends on trust, inclusiveness, transparency, and ethical oversight. Patients and clinicians alike seek clearer information on AI use in clinical settings, along with assurances of accountability, safety, and fairness.
By addressing these findings, AI4HF aims to foster a policy environment that supports innovation while protecting patients. Participation in IEEE Metroxraine 2025 provided a valuable platform to share these insights with the broader research and technology community, reinforcing AI4HF’s commitment to a human-centered, trustworthy, and policy-aligned approach to AI in healthcare.
Further updates on the study outcomes and their contribution to future AI governance frameworks will be shared as AI4HF progresses through its next project phases.